Trial Profile
Feasibility and safety of Infliximab enema treatment in patients with active left-sided ulcerative colitis. An open-label, non comparative, pilot study.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 May 2012
Price :
$35
*
At a glance
- Drugs Infliximab (Primary)
- Indications Ulcerative colitis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Cosmo Pharmaceuticals
- 24 Jul 2011 New trial record